Nutex Health Inc. (NASDAQ:NUTX) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Nutex Health Inc. (NASDAQ:NUTX) have received a consensus rating of “Moderate Buy” from the five brokerages that are presently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $268.3333.

Several equities analysts recently issued reports on NUTX shares. Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Zacks Research upgraded Nutex Health to a “hold” rating in a research note on Monday, June 29th. Lake Street Capital reiterated a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. Wall Street Zen downgraded shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 20th. Finally, B. Riley Financial assumed coverage on Nutex Health in a research note on Friday, June 26th. They issued a “buy” rating and a $290.00 target price on the stock.

Institutional Investors Weigh In On Nutex Health

Institutional investors have recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Nutex Health by 81.9% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,399 shares of the company’s stock worth $752,000 after buying an additional 1,980 shares in the last quarter. Empowered Funds LLC bought a new stake in Nutex Health during the second quarter worth about $7,720,000. United Capital Financial Advisors LLC acquired a new position in Nutex Health during the second quarter valued at approximately $722,000. Corient Private Wealth LP bought a new position in Nutex Health in the second quarter valued at approximately $1,142,000. Finally, Bank of America Corp DE acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $1,752,000. Institutional investors own 5.32% of the company’s stock.

Nutex Health Price Performance

NASDAQ NUTX opened at $190.62 on Thursday. Nutex Health has a 1 year low of $77.21 and a 1 year high of $204.00. The business’s fifty day moving average is $165.64 and its two-hundred day moving average is $130.79. The stock has a market capitalization of $1.31 billion, a P/E ratio of 7.48 and a beta of 0.24. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00.

Nutex Health (NASDAQ:NUTX) last issued its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, topping the consensus estimate of $4.95 by $4.43. The business had revenue of $210.75 million during the quarter, compared to analysts’ expectations of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. On average, research analysts forecast that Nutex Health will post 30.11 earnings per share for the current fiscal year.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.